Shanghai Fosun Pharmaceuti-h (2196.HK) traded up 1.03 % during a 24 hours period ending at 10:02 PM Central Europe on Tuesday 27th. One Shanghai Fosun Pharmaceuti-h stock can currently be bought for about HKD 16.43 on popular exchanges. Current supply of Shanghai Fosun Pharmaceuti-h stocks is 551.9 mn. Shanghai Fosun Pharmaceuti-h has a current market capitalization of HKD 44.5 bn and approximately HKD 27.1 mn worth of Shanghai Fosun Pharmaceuti-h was traded on exchanges in the last 24 hours. Since last month end, Shanghai Fosun Pharmaceuti-h has traded -5.56 % down. Simple moving average of last 200 days is at HKD 18.18. The highest price of past 52 weeks was recorded at HKD 24.42 on 11/03/2025. 52 weeks low was at HKD 14.9 on 06/29/2026.
Summary of the latest news for Shanghai Fosun Pharmaceuti-h
Shanghai Fosun Pharmaceutical (Group) has released its latest quarterly financial figures at an all‑quarter conference. Analysts anticipate a modest rise in earnings per share for the period, with the company’s revenue expected to show a small increase compared to the same quarter last year. Looking ahead, consensus estimates project a further improvement in earnings for the full fiscal year, while the overall revenue outlook remains slightly above the previous year’s level. The data suggest a continued, albeit gradual, strengthening of the company’s financial performance, reflecting stable growth in both profitability and sales volume.
Here is how related stocks have performed in the past 24 hours:
Mango Excellent Media L (300413.SZ) traded flat 0 % and now trades at CNY 23.48. Current market capitalisation for Mango Excellent Media L is CNY 45.2 bn. Current price/earnings ratio for Mango Excellent Media L is 67.01. MANGO EXCELLENT MEDIA CO L reported a decline in its stock price following the release of its AI‑generated film Sangdui: Future Destiny. The film, a 100‑minute feature produced through advanced AI techniques, achieved a modest opening of 1.19 million yuan in four days and an average audience of fewer than two viewers per screening. The disappointing box‑office performance has led to a sharp drop in the company’s shares, with the stock falling to a trading halt during the session. Despite the weak commercial response, the company’s management stated that the project was intended to demonstrate a new production model and that further AI‑film initiatives remain under development. The company’s overall earnings from AI‑driven content were small in proportion to its total revenue, though its profit margin on the AI segment was reported to be high. Market reaction has been negative, with several related stocks also experiencing declines.
Zhejiang Cfmoto Power L (603129.SS) traded flat 0 % and now trades at CNY 293.55. Zhejiang Cfmoto Power L has a market capitalisation of CNY 45.2 bn. Current price/earnings ratio for Zhejiang Cfmoto Power L is 20.15. ZHEJIANG CFMOTO POWER CO L’s recent disclosures indicate that institutional investors have increased their holdings in the company, reflecting confidence in its ongoing operations. The firm’s financial statements reveal a trend of stronger profitability and a modest expansion of its production capacity, supporting a positive outlook for its future earnings. The company’s focus on electric motorcycle manufacturing aligns with broader industry momentum toward sustainable mobility. Analysts note that the firm’s market valuation has become more attractive, suggesting that investors expect continued growth in demand for its products. The company’s cash‑flow position remains solid, providing flexibility for further investment in technology and capacity expansion. Overall, the recent data underscore a stable financial performance and a strategic emphasis on sustaining competitive advantage in the electric vehicle sector.
Orbbee (688322.SS) traded flat 0 % and now trades at CNY 106.85. Current market capitalisation for Orbbee is CNY 44.5 bn. Orbbee has a current price to earnings ratio of 460.15.
Anhui Jianghuai Auto (600418.SS) traded flat 0 % and now trades at CNY 19.8. Current market capitalisation for Anhui Jianghuai Auto is CNY 45.4 bn. Anhui Jianghuai Auto Group has attracted attention from analysts following recent developments in autonomous driving policy and industry momentum. The company’s inclusion among a select group of automotive firms whose earnings analysts predict could double in the year has highlighted its growing role in China’s smart‑vehicle sector. Industry observers note that the expansion of Level 3 and Level 4 testing approvals across major cities is expected to accelerate the commercial deployment of autonomous technologies. Anhui Jianghuai’s reported progress in vehicle‑testing infrastructure aligns with this broader regulatory push, suggesting the firm is positioned to benefit from the anticipated scaling of self‑driving solutions. Overall, market participants view the company’s trajectory positively, citing its participation in the fast‑growing smart‑driving ecosystem and its potential to capture increasing market share as testing and deployment programs expand.
Shandong Himile Mechanical (002595.SZ) traded flat 0 % and now trades at CNY 38.21. Shandong Himile Mechanical has a market capitalisation of CNY 44.5 bn. Shandong Himile Mechanical has a current price to earnings ratio of 19.09.
About Shanghai Fosun Pharmaceuti-h
Shanghai Fosun Pharmaceutical Group Co Ltd. is a health care company based in China with its main operations in Shanghai. The company specializes in the production of various pharmaceutical products, including genetic medicines, Chinese traditional medicines, diagnostic products, reagents, and other items. Additionally, they provide medical equipment. You can find more information about their offerings on their website at www.fosunpharma.com . The company went public at the Shanghai Stock Exchange on June 25, 1998.